EILEEN MEIER: Open Payments
NPI 1851847883 · FORT DODGE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 9 payments from 8 companies in 2025. Trend: 2023 $190 · 2024 $298 · 2025 $297
Food & beverage: $185Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Janssen Pharmaceuticals, Inc | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: FANAPT, INVEGA SUSTENNA, COBENFY, VRAYLAR, INGREZZA, REXULTI, Auvelity.
Industry payments across IA — which companies pay providers there.
